Terug
Ook genoteerd als
SEMHF
OTC
Dagbereik
€ 21,11
€ 21,50
52-Weeksbereik
€ 20,85
€ 28,92
Volume
11.980
50D / 200D Gem.
€ 24,54
/
€ 26,27
Vorige Slotkoers
€ 20,91
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 47,6 | 0,4 |
| P/B | 4,5 | 2,9 |
| ROE % | 10,3 | 3,7 |
| Net Margin % | 9,2 | 3,8 |
| Rev Growth 5Y % | 5,2 | 10,0 |
| D/E | 0,8 | 0,2 |
Belangrijkste Punten
Revenue grew 5,19% annually over 5 years — modest growth
ROE of 10,26% — decent returns on equity
Generating 2,14B in free cash flow
P/E of 47,59 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 6,67%
Cash machine — converts 105,64% of earnings into free cash flow
Groei
Revenue Growth (5Y)
5,19%
Revenue (1Y)-1,48%
Earnings (1Y)4,07%
FCF Growth (3Y)48,28%
Kwaliteit
Return on Equity
10,26%
ROIC6,24%
Net Margin9,17%
Op. Margin14,70%
Veiligheid
Debt / Equity
0,83
Current Ratio1,11
Interest Coverage8,08
Waardering
P/E Ratio
47,59
P/B Ratio4,54
EV/EBITDA34,50
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1,48% | Revenue Growth (3Y) | 0,81% |
| Earnings Growth (1Y) | 4,07% | Earnings Growth (3Y) | 15,73% |
| Revenue Growth (5Y) | 5,19% | Earnings Growth (5Y) | 4,01% |
| Profitability | |||
| Revenue (TTM) | 22,03B | Net Income (TTM) | 2,02B |
| ROE | 10,26% | ROA | 3,88% |
| Gross Margin | 38,63% | Operating Margin | 14,70% |
| Net Margin | 9,17% | Free Cash Flow (TTM) | 2,14B |
| ROIC | 6,24% | FCF Growth (3Y) | 48,28% |
| Safety | |||
| Debt / Equity | 0,83 | Current Ratio | 1,11 |
| Interest Coverage | 8,08 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 47,59 | P/B Ratio | 4,54 |
| P/S Ratio | 4,37 | PEG Ratio | 7,41 |
| EV/EBITDA | 34,50 | Dividend Yield | 0,02% |
| Market Cap | 96,18B | Enterprise Value | 111,71B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 22,03B | 22,36B | 21,68B | 21,71B | 18,00B |
| Net Income | 2,02B | 1,94B | 1,51B | 2,04B | 1,73B |
| EPS (Diluted) | 0,90 | 0,87 | 0,67 | 0,91 | 0,78 |
| Gross Profit | 8,51B | 8,47B | 7,71B | 8,14B | 6,95B |
| Operating Income | 3,24B | 3,30B | 2,44B | 3,06B | 2,78B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 52,13B | 46,06B | 46,68B | 49,06B | 41,93B |
| Total Liabilities | 30,88B | 27,81B | 28,55B | 29,20B | 25,87B |
| Shareholders' Equity | 21,20B | 18,20B | 18,08B | 19,84B | 16,04B |
| Total Debt | 17,70B | 16,21B | 16,65B | 16,65B | 14,32B |
| Cash & Equivalents | 2,18B | 2,68B | 1,64B | 1,44B | 1,32B |
| Current Assets | 16,57B | 14,44B | 14,14B | 13,38B | 10,78B |
| Current Liabilities | 14,86B | 11,57B | 13,44B | 12,02B | 10,11B |